As previously mentioned, mutations in NF2, the first ever identified driver of genetic pathogenesis in meningiomas, are responsible for the regulation and production of the key tumor suppressor protein Merlin which inhibits PI3K intracellular signaling pathways and activates the mammalian hippo signaling pathways. The gene discussed is NF2; the disease is meningioma.